Kiniksa Pharmaceuticals International Plc (KNSA)

Jan 20, 2025

Kiniksa Pharmaceuticals Reports Strong 2024 Financial Results and Provides 2025 Revenue Guidance - Defense World

Jan 20, 2025

Jan 15, 2025

Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $255,413 - Investing.com

Jan 15, 2025

Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025

Jan 13, 2025

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance - The Manila Times

Jan 13, 2025

Jan 13, 2025

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Kiniksa's ARCALYST Soars 79% to $416M in 2024, Projects Strong 2025 Growth to $580M - StockTitan

Jan 13, 2025

Jan 06, 2025

Kiniksa Pharmaceuticals to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 06, 2025

Jan 06, 2025

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Jan 06, 2025

Dec 18, 2024

Kiniksa Pharmaceuticals COO Tessari Eben sells shares worth $470k - Investing.com

Dec 18, 2024

Dec 11, 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Shares Acquired by Fmr LLC - Defense World

Dec 11, 2024

Dec 11, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $593,997 By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 10, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $593,997 - Investing.com

Dec 10, 2024

Dec 05, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $323,008 By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 05, 2024

Kiniksa Pharmaceuticals CFO sells shares worth $323,008 - Investing.com India

Dec 05, 2024

Dec 05, 2024

KNSA (Kiniksa Pharmaceuticals International) Treasury Stock : $0.0 Mil (As of Sep. 2024) - GuruFocus.com

Dec 05, 2024

Dec 02, 2024

Kiniksa Pharmaceuticals officer sells $194k in stock By Investing.com - Investing.com Nigeria

Dec 02, 2024

Dec 02, 2024

Kiniksa Pharmaceuticals officer sells $194k in stock - Investing.com India

Dec 02, 2024

Nov 30, 2024

Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com

Nov 30, 2024

Nov 26, 2024

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - Marketscreener.com

Nov 26, 2024

Nov 24, 2024

Principal Financial Group Inc. Sells 14,100 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World

Nov 24, 2024

Nov 20, 2024

Kiniksa Pharmaceuticals COO sells shares valued at $357,680 By Investing.com - Investing.com Nigeria

Nov 20, 2024

Nov 20, 2024

Kiniksa Pharmaceuticals COO sells shares valued at $357,680 - Investing.com India

Nov 20, 2024

Nov 15, 2024

HHLR Advisors, Ltd. Reduces Stake in Kiniksa Pharmaceuticals Int - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Is Kiniksa Pharmaceuticals (KNSA) Top Performing European Stock Heading into 2025? - Insider Monkey

Nov 13, 2024

Nov 12, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference 2024 | KNSA Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

10 Top Performing European Stocks Heading into 2025 - Insider Monkey

Nov 12, 2024

Nov 04, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Trading Down 3. - GuruFocus.com

Nov 04, 2024

Nov 01, 2024

Kiniksa Pharmaceuticals International, plc Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Yahoo Finance

Nov 01, 2024

Oct 31, 2024

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024

Oct 30, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earning - GuruFocus.com

Oct 30, 2024

Oct 30, 2024

Kiniksa Pharmaceuticals International Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Oct 30, 2024

Oct 30, 2024

Kiniksa Pharmaceuticals Reports Strong Q3 2024 Growth - TipRanks

Oct 30, 2024

Oct 30, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Q3 2024 Earnings Call Highlights: Impressive ... - Yahoo Finance

Oct 30, 2024

Oct 29, 2024

Kiniksa Pharm's Revenue Surges 67% in Q3 - The Motley Fool

Oct 29, 2024

Oct 29, 2024

Kiniksa Pharmaceuticals International PLC (KNSA) Shares Gap Down to $24.04 on Oct 29 - GuruFocus.com

Oct 29, 2024

Oct 29, 2024

Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 29, 2024

Oct 29, 2024

Kiniksa Pharmaceuticals Q3 2024 Earnings: EPS Miss, Revenue Beats Estimates with $112.2 Million - GuruFocus.com

Oct 29, 2024

Oct 29, 2024

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewswire

Oct 29, 2024

Oct 28, 2024

Exploring Kiniksa Pharmaceuticals's Earnings Expectations - Benzinga

Oct 28, 2024

Oct 28, 2024

What To Expect From Kiniksa Pharmaceuticals International PLC (K - GuruFocus.com

Oct 28, 2024